# US 2024/0180855 A1 · Bioactive products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0180855 A1
- Document ID: US20240180855A1
- Status: Published application
- Kind: A1
- Application number: 18/285,641
- Filed: 2022-04-05
- Published: 2024-06-06
- Earliest claimed: 2021-04-05
- Inventors: Victor TETS; Georgy TETS
- Web page: https://patentgrep.com/patent/US20240180855A1

## CPC

- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A01N 43/54: 1,3-Diazines; Hydrogenated 1,3-diazines
- A01N 43/82: five-membered rings with three ring hetero atoms
- A01N 47/28: Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N< (isoureas, isothioureas A01N47/42)
- A01N 47/44: Guanidine; Derivatives thereof
- A01N 59/16: Heavy metals; Compounds thereof
- A01N 63/50: Isolated enzymes; Isolated proteins (peptides A01N37/46)
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A01P 3/00: Fungicides
- A01P 21/00: Plant growth regulators
- A23K 20/105: Aliphatic or alicyclic compounds
- A23K 20/111: Aromatic compounds
- A23K 20/189: Enzymes
- A23K 20/26: Compounds containing phosphorus
- A23K 20/30: {Oligoelements}
- A23K 50/80: for aquatic animals, e.g. fish, crustaceans or molluscs
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0063: {Periodont}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/08: Solutions {(composition of solutions A61K47/00)}
- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/728: Hyaluronic acid
- A61K 31/785: Polymers containing nitrogen
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/42: Phosphorus; Compounds thereof
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K 47/26: Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 11/02: Nasal agents, e.g. decongestants
- A61P 13/10: of the bladder
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/06: Antipsoriatics
- A61P 17/08: Antiseborrheics
- A61P 27/02: Ophthalmic agents
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 31/22: for herpes viruses
- C02F 1/50: by addition or application of a germicide or by oligodynamic treatment {(C02F1/4606, C02F1/467, C02F1/76 take precedence)}
- A61K 9/0048: {Eye, e.g. artificial tears}
- C02F 2103/20: from animal husbandry
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A23K: FODDER
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C02F: TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE (separation in general B01D; special arrangements on waterborne vessels of installations for treating water, waste water or sewage, e.g. for producing fresh water, B63J; adding materials to water to prevent corrosion C23F; treating radioactively-contaminated liquids G21F9/04; regeneration of reactants for recirculation into processes, see the relevant places for the processes)

## Abstract

The present invention relates to the compounds and methods for controlling living organisms for their bioactivity, improving their habitat in order to increase the biological activity of living beings in various conditions, as well as the prevention and treatment of diseases of plants, animals and humans.

## Claims

### Claim 1

The product to be used in agriculture veterinary, medicine including M4 (Poly-N1-hydrazino (imino) methyl-1,6-hexanediamine and/or compositions of the M4 and zinc and/or glycerin and/or sorbitol and/or boron and/or mannitol salts and/or Sodium hydrogenphosphate and/or Sodium dihydrogen phosphate and/or manganese salts and/or glutamic acid hyaluronic acid and/or inhibitors of reverse transcription and/or integration/recombination and/or proteases, and/or DNAse and/or RNAse, and/or DNAse+RNAse and/or VTL having a bioactive effect and/or the ability to control the activity of cells and/or to act on the properties of cells and/or group of cells controlled by DNA and/or RNA receptors of cells to improve the properties of plants and/or animals and/or the properties of water and/or soil, as well as the prevention and/or treatment of diseases of plants, animals and humans.

### Claim 2

The method of increasing germination, intensity and growth rate, stress tolerance, product and grain yield, chlorophyll formation and productivity of plants, increasing the productivity of aquacultures, fertilizing fish, cultivating soil, water, breeding aquatic animals and aquariums, increasing the safety of feed for farm animals and aquacultures, preventing and treating diseases and condition management (or condition correction) of plants, animals and people.

### Claim 3 (depends on 1)

The product according to claim 1 are fry forms, powders, solutions, gels and/or emulsions and/or ointments, additionally including hydrophilic ointment bases, including lightly crosslinked acrylic polymers, and/or lipophilic hydrocarbon, fatty, silicone and other components.

### Claim 4 (depends on 1)

The product according to claim 1, wherein the product is a complex of DNAse (from 0.1 μg/ml to 500.0 μg/ml), and/or RNAse (from 0.1 μg/ml to 500.0 μg/ml), and/or DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and/or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), and/or integration/recombination inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), and/or proteases (from 0.1 μg/ml to 5000.0 μg/ml), intended for the prevention and treatment of animals and humans.

### Claim 5 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) of glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products, which are used to increase the productivity of agricultural and/and whether ornamental and/or forest and/or domestic plants and/or aquaculture are used for the regulation of the plants properties with a non-limiting examples to accelerate/enhance growth rate, propagation, breeding, productivity, germination rate, flowering, modulating flowering in plants (acceleration and/or delaying the time to flowering) and/or increasing and/or decreasing the duration of flowering, increasing of organ size, vigor, photosynthetic area, number of leaves, flowers and/or plants root length, number of pods, improve the tillering, flowability and plantability, blooming, safety of crops in plants, plant height, cations content increases, biomass increases, sprout growth increases, increased grain yield, more early and sprouting and fruiting, increased/or altered Oil, starch, protein, Nutrients, Vitamins, fatty-acids, amino acids, sugars, plant weight, fiber length modulate senescence, increasing number of plants capable of growing in a given area ameliorates negative effects of hypoxia, darkness, drying, flooding, cold, soil salinity, nutrient or mineral or nitrogen deficiency, stress tolerance to other negative biological, chemical and physical effects

### Claim 6 (depends on 1)

The product according to claim 1, wherein the product M4 in an amount from 0.001 μg/ml to 10e5 μg/ml and/or a composition of M4 and zinc and/or glycerol and/or sorbitol and/or mannitol and/or sodium hydrogen phosphate and/or sodium dehydrogen phosphate and/or salts of boron and/or glutamate and/or manganese, which is used for the treatment of soil and/or water bodies to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture

### Claim 7 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 in an amount from 0.001 μg/ml to 10e5 μg/ml and zinc salt (from 0.1 μg/ml to 5000.0 μg/ml), and/or glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts and/or (from 0.1 μg/ml to 5000.0 μg/ml), and/or mannitol (from 0.1 μg/ml to 5000.0 μg/ml), and/or salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), and/or salts of dihydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml) and/or manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), and/or glucuronic acid soda (from 0.1 μg/ml to 5000.0 μg/ml) which is used to increase the productivity of agricultural and/or forest and/or domestic plants and/or ornamental and/or aquaculture due to seed dressing and/or treatment of roots and/or vegetative parts of the plant.

### Claim 8 (depends on 1)

The product according to claim 1 that is used for the regulation of plants' growth within farms (including vertical farms) of selected from the group consisting of a tree, a herb, a bush, a grass, a vine, a fem, moss and, a green algae, a monocotyledonous plant, and a dicotyledonous plant, including wheat, soy, rice, sugar cane, potato, barley, maize, oat, rice, sorghum, sugar cane, tomato, hybrid plants, new plants sugarcane, corn, cotton, grapes, bananas, cassava, beans, nuts, oil crops etc.

### Claim 9 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 in an amount from 0.001 μg/ml to 10e5 μg/ml, zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) and DNAse (from 0.1 μg/ml to 500.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquacultures by treating seeds and/or treating the roots and/or vegetative parts of the plant.

### Claim 10 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 in an amount from 0.001 μg/ml to 10e5 μg/ml, zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) and RNAse (from 0.1 μg/ml to 500.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquacultures by treating seeds and/or treating the roots and/or vegetative parts of the plant.

### Claim 11 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 in an amount from 0.001 μg/ml to 10e5 μg/ml, zinc salts (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml) and RNAse (from 0.1 μg/ml to 500.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture

### Claim 12 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 in an amount from 0.001 μg/ml to 10e5 μg/ml, zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) and DNAse (from 0.1 μg/ml to 500.0 μg/ml) and Raltegravir (from 0.1 μg/ml to 5000.0 g/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture through seed treatment and/or root treatment and/or vegetative parts of the plant.

### Claim 13 (depends on 1)

The product according to claim 1, wherein the product is a complex of DNAse (from 0.1 μg/ml to 500.0 μg/ml) or RNAse (from 0.1 μg/ml to 500.0 μg/ml) or DNAse mRNAse (from 0.1 μg/ml to 500.0 μg/ml) and Raltegravir (from 0.1 μg/ml to 5000.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture through seed treatment and/or root treatment and/or vegetative parts of the plant.

### Claim 14 (depends on 1)

The product according to claim 1, wherein the product is a complex of DNAse (from 0.1 μg/ml to 500.0 μg/ml) or RNAse (from 0.1 μg/ml to 500.0 μg/ml) or DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and protease inhibitors (lopinavir/ritonavir) (from 0.1 μg/ml to 5000.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture through seed treatment and/or root treatment and/or vegetative parts of the plant.

### Claim 15 (depends on 1)

The product according to claim 1, wherein the product is a complex of M4 (0.001 μg/ml to 10e5 μg/ml and/or DNAse (from 0.1 μg/ml to 500.0 μg/ml) or RNAse (from 0.1 μg/ml to 500.0 μg/ml) or DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and protease inhibitors (lopinavir/ritonavir) (from 0.1 μg/ml to 5000.0 μg/ml), which is used to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquaculture through seed treatment and/or root treatment and/or vegetative parts of the plant.

### Claim 16 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) of glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the listed products that are used for processing fish eggs in order to increase the efficiency of supplementation, sex management and infection control.

### Claim 17 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml), glycerol (from 0.1 μg/ml to 5000.0 μg/ml), sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml up to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), and complexes of the listed products that are used to increase the growth rate of weight gain, and other vital and commercially important characteristics of animals and aquaplankton due to treatment feed.

### Claim 18 (depends on 1)

A product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 g/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml), glycerol (from 0.1 μg/ml to 5000.0 μg/ml), sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml up to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) of the complexes of the listed products, as well as their forms, which are gels and/or emulsions and/or ointments and/or sol bores that are used to prevent and treat hoof rot and/or animal skin diseases

### Claim 19 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml), glycerol (from 0.1 μg/ml to 5000.0 μg/ml), sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml up to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) of the complexes of the listed products, as well as their forms, which are gels and/or emulsions and/or ointments and/or sol ora, which is used to treat eye diseases with conjunctivitis and dacryocystitis

### Claim 20 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) of glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 g/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the listed products, which are gels and/or emulsions and/or ointments and/or solutions that are used is used to correct the condition of the oral cavity, including periodontal and endodontic mucosa, as well as cysts and granulomas.

### Claim 21 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) of glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the listed products that are used to correct the condition of the skin, subcutaneous tissue and/and whether the eyes and/or mucous membranes of animals and humans with various diseases, including seborrheic dermatitis, neuroderma, Psoriasis, Herpes, papillomatosis, mycoses, erysipelas, trophic and diabetic ulcers, trauma, acne bedsores, folliculitis, furunculosis, angulitis (seizure) alopecia.

### Claim 22 (depends on 1)

The product according to claim 1, wherein the product is M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) of glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) salts of manganese (from 0.1 μg/ml to 5000.0 μg/ml), glutamic acid salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 g/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products that are used to correct the condition of the sinuses and/or urinary mucosa bladder.

### Claim 23 (depends on 2)

The method according to claim 2 wherein the soil and/or water bodies in order to increase the productivity of agricultural and/or forest and/or domestic plants and/or aquacultures are treated with the M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), dihydrophosphate salts (from 0.1 μg/ml to 5000.0 μg/ml) manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), exposure time is from 10 seconds to 24 hours or from 24 hours to 365 days

### Claim 24 (depends on 2)

The method according to claim 2, wherein the soil and/or water bodies in order to increase the productivity of agricultural and/or ornamental and/or forest and/or domestic plants and/or aquacultures are treated with the M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 g/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), the exposure time is from 10 seconds to 24 hours and after exposure, the product is inactivated by adding carboxymethylcellulose and/or sodium alginate in a ratio with the products 0.5-1.0 to 100.0-1.0

### Claim 25 (depends on 2)

The method according to claim 2, wherein reservoirs with running water are treated with products and the addition of the product ensures that the required final concentration of the M4 is maintained in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), salts glutamate (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) manganese salts (from 0.1 μg/ml to 5000.0 μg/ml)

### Claim 26 (depends on 2)

The method according to claim 2, wherein exposure to plants, root and/or non-root method, and/or spraying for application to the surface of vegetative shoots—leaves and stems and/or hydroponics and/or fertigation, for which M4 is used in an amount of 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), dihydrophosphate salts (from 0.1 μg/ml to 5000.0 μg/ml) manganese salts (from 0.1 μg/ml to 5000.0 μg/ml)

### Claim 27 (depends on 2)

The method according to claim 2, for exposure to plants, root and/or foliar method, and/or spraying for application to the surface of vegetative shoots, leaves and stems and/or hydroponics and/or fertigation, for which M4 is used in an amount of 0.001 μg/ml to 10e5 μg/ml or compositions of M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), followed by inactivation with carboxymethyl cellulose, sodium alginate in ratio with the products 0.5-1.0 to 100.0-1.0

### Claim 28 (depends on 2)

The method according to claim 2, to influence the eggs and fish eggs, to increase the efficiency of fertilization, and to control sex, the M4 is used in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the listed products and the treatment lasts from 3 seconds to 1 hour or from 1 hour to 120 hours.

### Claim 29 (depends on 2)

The method according to claim 2, for the effect on fish and/or crustaceans and/or molluscs to increase productivity, stress tolerance, increase of the growth rate, M4 is used in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml up to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrogen phosphates (from 0.1 μg/ml up to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), and the treatment lasts from 3 seconds to 24 hours or from 24 hours to 120 hours

### Claim 30 (depends on 2)

The method according to claim 2, for the effect on fish and/or crustaceans and/or molluscs to increase productivity, stress tolerance, increase of the growth rate, with M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), is introduced into the water where the fish are located and remains there indefinitely and/or is inactivated by carboxymethyl cellulose, sodium alginate in a ratio with the product 0.5-1, 0 to 100.0-1.0

### Claim 31

The method according to P1.2 of exposure to fish and/or crustaceans and/or molluscs, which includes their treatment with the product, and release into water, also pre-treated with the product.

### Claim 32 (depends on 2)

The method according to claim 2, in which to increase the growth rate, weight gain, and other vital and commercially important characteristics of animals and aquaplankton, the feed is treated before feeding with M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml up to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml).

### Claim 33 (depends on 2)

The method according to claim 2, wherein to increase the growth rate, weight gain, and other vital and commercially important characteristics of animals and aquaplankton, feed is treated before feeding with M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or M4 compositions and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml up to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), followed by inactivation with carboxymethyl cellulose, sodium alginate in a ratio with the products 0.5-1.0 to 100, 0-1.0

### Claim 34 (depends on 2)

The method according to claim 2, wherein to increase germination, growth intensity, chlorophyll formation and yield when pelleting seeds for 3 seconds to 24 hours, treatment is carried out using the M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 g/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 m kg/ml) and complexes of the listed products

### Claim 35 (depends on 2)

The method according to claim 2, wherein to increase germination, growth intensity, chlorophyll formation and yield when pelleting seeds for 3 seconds to 24 hours, treatment is carried out using the M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), followed by inactivation with carboxymethyl cellulose, sodium alginate in a ratio with the product 0.5-1.0 up to 100.0-1.0 or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products

### Claim 36 (depends on 2)

The method according to claim 2, to increase germination, growth rate, chlorophyll formation and yield, seed dressing is performed for 1.0 minutes to 24 hours using M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml up to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and cops of the listed products

### Claim 37 (depends on 2)

The method according to claim 2, wherein to increase germination, growth intensity, chlorophyll formation and yield, seed dressing is performed for 1.0 minutes to 24 hours using M4 in an amount of 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml up to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 g/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml) of manganese salts (from 0.1 μg/ml to 5000.0 g/ml), followed by inactivation with carboxymethyl cellulose, sodium alginate in a ratio with the products 0.5-1.0 to 100, 0-1.0 or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products

### Claim 38 (depends on 2)

The method according to claim 2, wherein to increase germination, growth intensity, chlorophyll formation and yield, seed dressing is performed for 1.0 minutes to 24 hours using M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml up to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and cops of the listed followed by planting in soil pre-treated with the same products

### Claim 39 (depends on 2)

The method according to claim 2, wherein for the bioactivation of the prevention and treatment of diseases of bees and increasing the amount of honey obtained, the hive is treated and fed with M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to 5000.0 μg/ml), boron salts (from 0.1 μg/ml to 5000.0 μg/ml), glutamate salts (from 0.1 μg/ml to 5000.0 μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), dihydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml) manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml up to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products

### Claim 40 (depends on 2)

The method according to claim 2, wherein correcting the condition of the skin and/or subcutaneous tissue of animals and humans in various diseases, including seborrheic dermatitis, neuroderma, Psoriasis, Herpes, papillomatosis, mycoses, erysipelas, trophic and diabetic ulcers, trauma, acne bedsores, folliculitis, furunculosis, angulitis (jam) alopecia using M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), dihydrophosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), hyaluronic acid salts or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml d about 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products, while the products are gels and/or emulsions and/or ointments and/or liquids

### Claim 41 (depends on 2)

The method according to claim 2, wherein correcting the state of the mucous membranes of the sinuses and/or the mucous membranes of the urinary bladder, in which using the product M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml up to 5000.0 μg/ml), dihydrophosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), hyaluronic acid salts or reverse transcription inhibitors (from 0.1 μg/ml up to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 g/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products, while the products are gels and/or emulsions and/or liquid, in which the product is injected into the cavity for processing tissue and is either removed after washing or inactivated or remains in the cavity and endodontics, as well as cysts and granulomas using M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), salts of hydrogen phosphates (from 0.1 μg/ml to 5000.0 μg/ml), salts of dihydrophosphates (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), hyaluronic acid salts or reverse transcription inhibitors (from 0.1 μg/ml to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 μg/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml up to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products, while the products are gels and/or emulsions and/or liquids,

### Claim 42 (depends on 2)

The method according to claim 2, wherein correction for correcting the condition of the eyes, including conjunctivitis and dacryocystitis, using the M4 in an amount from 0.001 μg/ml to 10e5 μg/ml or compositions M4 and zinc salts (from 0.1 μg/ml to 5000.0 μg/ml) glycerol (from 0.1 μg/ml to 5000.0 μg/ml) sorbitol (from 0.1 μg/ml to μg/ml), mannitol (from 0.1 μg/ml to 5000.0 μg/ml), hydrogen phosphate salts (from 0.1 μg/ml up to 5000.0 μg/ml), dihydrophosphate salts (from 0.1 μg/ml to 5000.0 μg/ml), manganese salts (from 0.1 μg/ml to 5000.0 μg/ml), hyaluronic acid salts or reverse transcription inhibitors (from 0.1 μg/ml up to 5000.0 μg/ml), integration/recombination (from 0.1 μg/ml to 5000.0 g/ml), proteases (from 0.1 μg/ml to 5000.0 μg/ml), DNAse (from 0.1 μg/ml to 500.0 μg/ml), RNAse (from 0.1 μg/ml to 500.0 μg/ml), DNAse+RNAse (from 0.1 μg/ml to 500.0 μg/ml) and complexes of the above products, while the products are gels and/or emulsions and/or liquids.
